Gonorrhea-Market-Insights

DelveInsigth’s Gonorrhea market report offers comprehensive coverage of the current treatment practices, emerging drugs, Gonorrhea market share of the individual therapies, current and forecasted Gonorrhea market size from 2018 to 2030 segmented into 7MM (the United States, EU5 (Germany, Spain, Italy, France, and the UK), and Japan).

Key Highlights from the Gonorrhea Market Report

  • According to the Centers for Disease Control and Prevention (CDC), Gonorrhea is the second most commonly reported notifiable disease in the United States. Over 580,000 Gonorrhea cases were reported in the United States in 2018.
  • According to Kirkcaldy et al. (2019), Gonorrhea prevalence among women was highest in the Americas (0.9 percent) and lowest in Europe (0.3 percent ).
  • Key pharmaceutical companies such as Evofem Biosciences, GlaxoSmithKline, Entasis Therapeutics, GARDP, and others are developing therapies for Gonorrhea. 
  • Key pipeline therapies in the Gonorrhea therapeutics market include EVO100, Gepotidacin (GSK2140944), Zoliflodacin (ETX0914), and several others.
  • EVO100 is an investigational drug candidate developed by Evofem Biosciences. It is a vaginal gel that is intended to reduce certain vaginal infections by balancing vaginal pH, thereby maintaining healthy vaginal flora and creating an environment that is detrimental to the growth and proliferation of harmful bacteria.
  • Gepotidacin (GSK2140944) is a novel triaza acenaphthylene topoisomerase inhibitor antibiotic developed by GSK with a novel “dual targeting” mechanism of action and oral formulation.
  • Zoliflodacin (ETX0914) is the first of a novel class of molecules developed for the treatment of uncomplicated gonorrhea. Entasis collaborated with the Global Antibiotic Research and Development Partnership (GARDP) to develop Zoliflodacin.

Request for the Webex demo of the report @ Gonorrhea Market Outlook

The Gonorrhea market report also discusses current Gonorrhea treatment practices/algorithms, Gonorrhea market drivers, Gonorrhea market barriers, and unmet medical needs.

Gonorrhea Overview

Gonorrhea is a sexually transmitted disease (STD) caused by a bacterium called Neisseria gonorrhoeae. N. gonorrhoeae infects the reproductive tract’s mucous membranes, including the cervix, uterus, and fallopian tubes in women and the urethra in both men and women. N. gonorrhoeae can also infect the mouth, throat, eyes, and rectum’s mucous membranes.

Gonorrhea Epidemiology Segmentation

The Gonorrhea report proffers epidemiological analysis for the study period 2018-30 in the 7MM segmented into:

  • Gonorrhea Total Prevalent Cases
  • Gonorrhea Total Diagnosed Cases 
  • Gonorrhea Age-Specific Cases
  • Gonorrhea Gender-Specific Cases
  • Gonorrhea Total Treated Cases

Get the complete epidemiology segmentation analysis @ Gonorrhea Epidemiology Analysis

Gonorrhea Treatment Landscape

There are antibiotic treatments available for Gonorrhea treatments. Because some strains of Gonorrhea have been found to be resistant to certain drugs, the recommended treatment for the majority of cases consists of two antibiotics: one administered via injection and the other via oral medication (usually just a single pill). The antibiotics that are used for Gonorrhea treatment are Ceftriaxone and Azithromycin.

 Get more details about the current gonorrhea treatment @ Gonorrhea Treatment Guidelines

Gonorrhea Market

The Gonorrhea market size will expand during the forecast period, 2021–2030, due to the rising prevalence of Gonorrhea. The Gonorrhea market is expected to grow in size due to the launch of emerging therapies such as EVO100, Gepotidacin, and others during the study period (2018-30).

Gonorrhea Pipeline Therapies and Key Companies

  • EVO100: Evofem Biosciences
  • Gepotidacin: GlaxoSmithKline
  • Zoliflodacin: Entasis/GARDP

Learn more about the emerging drugs and companies @ Gonorrhea Therapeutics Market 

Gonorrhea Market Drivers

  • Increasing prevalence of Gonorrhea
  • Improved awareness on Gonorrhea and STDs

Gonorrhea Market Barriers

  • Some strains of gonorrhea have been found to be resistant to certain drugs conferring antibiotic resistance
  • The low voluntary screening rate for the disease 

Scope of the Report

Coverage: 7MM (the US, EU5 (the UK, Germany, Italy, Spain, and France) and Japan)

Study Period: 2018-30

Gonorrhea Key Companies: Evofem Biosciences, GlaxoSmithKline, Entasis Therapeutics, GARDP, among others. 

Gonorrhea Key Pipeline Therapies: EVO100, Gepotidacin (GSK2140944), Zoliflodacin (ETX0914), and others.

Gonorrhea Segmentation: By Geography, Gonorrhea drugs

Analysis: Comparative and conjoint analysis of  Gonorrhea emerging therapies

Tools Used: SWOT Analysis

Case Studies

KOL’s Views

Analyst’s Views

Table of Contents

1.

Key Insights

2.

Executive Summary of Gonorrhea

3.

SWOT Analysis of Gonorrhea

4.

Gonorrhea: Market Share (%) Distribution Overview at a Glance: By Country

5.

Gonorrhea Epidemiology and Market Methodology

6.

Gonorrhea: Disease Background and Overview

7.

Gonorrhea Epidemiology and Patient Population

8.

Gonorrhea Epidemiology Scenario: 7MM

9.

Gonorrhea The United States Epidemiology

10.

Gonorrhea EU-5 Epidemiology

11.

Gonorrhea Japan Epidemiology

12.

Gonorrhea Current Treatment Practices

13.

Gonorrhea Unmet Needs

14.

Patient Journey of Gonorrhea

15.

Key Endpoints in Gonorrhea Clinical Trials

16.

Gonorrhea Marketed Therapies

17.

Gonorrhea Emerging Therapies

18.

Conjoint Analysis of Gonorrhea

19.

Gonorrhea: Seven Major Market Analysis

20.

Gonorrhea 7MM Market Size

21.

Gonorrhea United States Market Size

22.

Gonorrhea EU-5 Market Size

23.

Gonorrhea Japan Market Size

24.

Market Access and Reimbursement of Gonorrhea Therapies

25.

Gonorrhea Market Drivers

26.

Gonorrhea Market Barriers

27.

Appendix

28.

DelveInsight Capabilities

29.

Disclaimer

30.

About DelveInsight

Know more about report offerings @ Gonorrhea Market Research

Related Reports

Multi-Drug-Resistant (MDR) Neisseria Gonorrhoeae Market

DelveInsight’s “Multi-Drug-Resistant (MDR) Neisseria Gonorrhoeae – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Multi-Drug-Resistant (MDR) Neisseria Gonorrhoeae, historical and forecasted epidemiology as well as the Multi-Drug-Resistant (MDR) Neisseria Gonorrhoeae market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Human Papillomavirus Market

Get comprehensive historical and forecast analysis of Human Papillomavirus Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as Inovio Pharmaceuticals, ISA Pharmaceuticals, Vaccibody A/S, among others. 

Human Papillomavirus (HPV) Associated Disorders Market

DelveInsight’s “Human Papillomavirus (HPV) Associated Disorders – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Human Papillomavirus (HPV) Associated Disorders, historical and forecasted epidemiology as well as the Human Papillomavirus (HPV) Associated Disorders market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

HPV-induced Cutaneous Tumors Market

DelveInsight’s “HPV-induced Cutaneous Tumors – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the HPV-induced Cutaneous Tumors, historical and forecasted epidemiology as well as the HPV-induced Cutaneous Tumors market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Human Papillomavirus 16+ Cancers Market

Get comprehensive historical and forecast analysis of Human Papillomavirus 16+ Cancers Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as Merck, GlaxoSmithKline, PDS Biotechnology, Merck, Cue Biopharma, ISA Pharmaceuticals, Regeneron Pharmaceuticals, Vaccibody AS, Roche, among others.

 Dysmenorrhea Market

Get comprehensive historical and forecast analysis of Dysmenorrhea Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as AbbVie, Neurosciences Biosciences, Nobelpharma, ASKA Pharmaceutical, ObsEva, Myovant Sciences, Takeda, among others.

Erectile Dysfunction Market

DelveInsight’s “Erectile Dysfunction – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Erectile Dysfunction, historical and forecasted epidemiology as well as the Erectile Dysfunction market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Uterine Fibroids Market

DelveInsight’s “Uterine Fibroids – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Uterine fibroids, historical and forecasted epidemiology as well as the Uterine fibroids market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Anovulation Market

DelveInsight’s “Anovulation Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Anovulation, historical and forecasted epidemiology as well as the Anovulation market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Prostate Cancer Market

Get comprehensive historical and forecast analysis of Prostate Cancer Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as Bayer Health Care, Astellas Pharma, Amgen, Janssen Pharmaceutical, Sanofi, Orion Corporation, among others.

For rich insights into Healthcare and Pharmaceutical News, visit Pharma, Healthcare, and Biotech Blog Posts

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance. 
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

Connect With Us at:
LinkedIn | Facebook | Twitter

Tags: Gonorrhea Therapies, Gonorrhea Pipeline, Gonorrhea Epidemiology, Gonorrhea Therapeutics, Gonorrhea Treatment, Gonorrhea Market, Gonorrhea